MC-105: A Phase III Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Curexcell as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers.

Project: Research project

Project Details

StatusFinished
Effective start/end date7/18/14 → 7/18/17

Funding

  • Amarex Clinical Research (Prot # MC-105 // Prot # MC-105)
  • MacroCure, Ltd. (Prot # MC-105 // Prot # MC-105)